Successful management of massive lamotrigine extended-release intoxication in a dog

被引:0
作者
McLaine, Alexis S. [1 ]
Yaxley, Page E. [1 ]
Young, Anda A. [1 ]
Cooper, Edward S. [1 ]
机构
[1] Ohio State Univ, Dept Vet Clin Sci, Columbus, OH 43210 USA
来源
CLINICAL CASE REPORTS | 2021年 / 9卷 / 12期
关键词
cardiovascular disorders; lamotrigine; neurologic disorders; toxicology; veterinary; INTRAVENOUS LIPID EMULSION; PHARMACOLOGICAL-PROPERTIES; PHARMACOKINETICS; TOXICITY; OVERDOSE; CHARCOAL; THERAPY;
D O I
10.1002/ccr3.5169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 3-year-old spayed female Siberian Husky presented for evaluation following ingestion of approximately 429 mg/kg of lamotrigine extended-release. She demonstrated severe neurologic and cardiac signs and was treated with lipid emulsion, anticonvulsants, antiarrhythmics and aggressive decontamination and supportive care. She was successfully discharged from the hospital 5 days later.
引用
收藏
页数:10
相关论文
共 50 条
[41]   Extended-release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate-release formulations [J].
Leppik, Ilo E. ;
Hovinga, Collin A. .
EPILEPSIA, 2013, 54 (01) :28-35
[42]   Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction [J].
Sundra, Tania ;
Kelty, Erin ;
Rossi, Gabriele ;
Rendle, David .
FRONTIERS IN VETERINARY SCIENCE, 2024, 11
[43]   Severe constipation associated with extended-release bupropion therapy [J].
Lounsbery, Jody L. ;
Medow, Mitchell A. ;
Green, Christopher G. .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (16) :1530-1532
[44]   Extended-release gabapentin in post-herpetic neuralgia [J].
Thomas, Ben ;
Farquhar-Smith, Paul .
EXPERT OPINION ON PHARMACOTHERAPY, 2011, 12 (16) :2565-2571
[45]   Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia [J].
Hussein, Ayman A. ;
Nicholls, Stephen J. .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2010, 6 :183-190
[46]   Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone [J].
Haeseler, Gertrud ;
Schaefers, Dirk ;
Prison, Natalie ;
Ahrens, Joerg ;
Liu, Xiaofei ;
Karch, Annika .
BMC ANESTHESIOLOGY, 2017, 17
[47]   Potential of Mirabegron and its Extended-release Formulations for the Treatment of Overactive Bladder Syndrome [J].
Mandpe, Pankaj ;
Pralhakar, Bala ;
Shende, Pravin .
CURRENT DRUG METABOLISM, 2020, 21 (02) :79-88
[48]   A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine [J].
Jacobs, Bart A. W. ;
Meulenaar, Jelte ;
Rosing, Hilde ;
Pluim, Dick ;
Tibben, Matthijs M. ;
de Vries, Niels ;
Nuijen, Bastiaan ;
Huitema, Alwin D. R. ;
Beijnen, Jos H. ;
Schellens, Jan H. M. ;
Marchetti, Serena .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) :1201-1207
[49]   Sustained-Release, Extended-Release, and Other Time-Release Formulations in Neuropsychiatry [J].
Andrade, Chittaranjan .
JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (08) :E995-E999
[50]   THIRD-DEGREE AV BLOCK FROM EXTENDED-RELEASE DILTIAZEM INGESTION IN A NINE-MONTH-OLD [J].
Wills, Brandon K. ;
Liu, J. Marc ;
Wahl, Michael .
JOURNAL OF EMERGENCY MEDICINE, 2010, 38 (03) :328-331